<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">LORATADINE <img border="0" src="../images/pr.gif"/></span><br/>(lor'a-ta-deen)<br/><span class="topboxtradename">Alavert, </span><span class="topboxtradename">Claritin, </span><span class="topboxtradename">Claritin Reditabs<br/></span><b>Classifications:</b> <span class="classification">antihistamine</span>; <span class="classification">h<sub>1</sub>-receptor antagonist</span>; <span class="classification">nonsedating</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>10 mg tablets; 1 mg/mL syrup</p>
<h1><a name="action">Actions</a></h1>
<p>Long-acting antihistamine with selective peripheral H<sub>1</sub>-receptor sites, thus blocking histamine release.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Long-acting H<sub>1</sub>-receptor antagonist of histamine that disrupts capillary permeability and edema formation and constriction of respiratory,
         GI, and vascular smooth muscle.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Relief of symptoms of seasonal allergic rhinitis; idiopathic chronic urticaria.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to loratadine.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hepatic and renal impairment, pregnancy (category B), lactation. Safety and effectiveness in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Allergic Rhinitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 10 mg once/d on an empty stomach; start patients with liver disease with 10 mg every other day<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 30 kg, 5 mg q.d.; &gt;<i>30 kg,</i> 10 mg q.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give on an empty stomach, 1 h before or 2 h after a meal.</li>
<li>Store in a tightly closed container.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Dizziness, dry mouth, fatigue, headache, somnolence, altered salivation and lacrimation, thirst, flushing, anxiety, depression,
      impaired concentration. <span class="typehead">CV:</span> Hypotension, hypertension, palpitations, syncope, tachycardia. <span class="typehead">GI:</span> Nausea, vomiting, flatulence, abdominal distress, constipation, diarrhea, weight gain, dyspepsia. <span class="typehead">Body as a Whole:</span> Arthralgia, myalgia. <span class="typehead">Special Senses:</span> Blurred vision, earache, eye pain, tinnitus. <span class="typehead">Skin:</span> Rash, pruritus, photosensitivity. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 13 h. <span class="typehead">Peak:</span> 812 h; reaches steady state levels in 35 d. <span class="typehead">Duration:</span> 24 h. <span class="typehead">Distribution:</span> Distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized to active metabolite, descarboethoxyloratidine, in the liver. <span class="typehead">Elimination:</span> Excreted in urine and feces. <span class="typehead">Half-Life:</span> 1215 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess carefully for and report distressing or dangerous S&amp;S that occur after initiation of the drug. A variety of adverse
            effects, although not common, are possible. Some are an indication to discontinue the drug.
         </li>
<li>Monitor cardiovascular status and report significant changes in BP and palpitations or tachycardia.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Drug may cause significant drowsiness in older adult patients and those with liver or kidney impairment.</li>
<li>
            							Note: Concurrent use of alcohol and other CNS depressants may have an additive effect.
            						
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>